Krystexxa Interactions
There are 34 drugs known to interact with Krystexxa (pegloticase), along with 2 disease interactions. Of the total drug interactions, 5 are major, and 29 are moderate.
- View all 34 medications that may interact with Krystexxa
- View Krystexxa disease interactions (2)
Most frequently checked interactions
View interaction reports for Krystexxa (pegloticase) and the medicines listed below.
- allopurinol
- amlodipine
- Aranesp (darbepoetin alfa)
- atorvastatin
- carvedilol
- colchicine
- Eliquis (apixaban)
- Enbrel (etanercept)
- Entyvio (vedolizumab)
- ezetimibe
- febuxostat
- folic acid
- gabapentin
- Lasix (furosemide)
- lisinopril
- losartan
- magnesium oxide
- methotrexate
- metoprolol
- prednisone
- Remicade (infliximab)
- sildenafil
- Stelara (ustekinumab)
- tramadol
- turmeric
- Tysabri (natalizumab)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Krystexxa disease interactions
There are 2 disease interactions with Krystexxa (pegloticase) which include:
Report options
QR code containing a link to this page
More about Krystexxa (pegloticase)
- Krystexxa consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (18)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antihyperuricemic agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.